Catheter Precision Statistics
Total Valuation
VTAK has a market cap or net worth of $2.51 million. The enterprise value is $6.27 million.
Important Dates
The next estimated earnings date is Tuesday, August 11, 2026, after market close.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
VTAK has 2.69 million shares outstanding. The number of shares has increased by 529.09% in one year.
| Current Share Class | 2.69M |
| Shares Outstanding | 2.69M |
| Shares Change (YoY) | +529.09% |
| Shares Change (QoQ) | +28.40% |
| Owned by Insiders (%) | 14.97% |
| Owned by Institutions (%) | 10.66% |
| Float | 2.29M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.07 |
| Forward PS | 0.24 |
| PB Ratio | 0.23 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.66 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.10, with a Debt / Equity ratio of 0.58.
| Current Ratio | 0.10 |
| Quick Ratio | 0.06 |
| Debt / Equity | 0.58 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -43.35 |
Financial Efficiency
Return on equity (ROE) is -192.25% and return on invested capital (ROIC) is -63.17%.
| Return on Equity (ROE) | -192.25% |
| Return on Assets (ROA) | -34.90% |
| Return on Invested Capital (ROIC) | -63.17% |
| Return on Capital Employed (ROCE) | -101.91% |
| Weighted Average Cost of Capital (WACC) | 5.72% |
| Revenue Per Employee | $37,227 |
| Profits Per Employee | -$781,045 |
| Employee Count | 22 |
| Asset Turnover | 0.04 |
| Inventory Turnover | 1.06 |
Taxes
| Income Tax | -1.81M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -83.06% in the last 52 weeks. The beta is 0.25, so VTAK's price volatility has been lower than the market average.
| Beta (5Y) | 0.25 |
| 52-Week Price Change | -83.06% |
| 50-Day Moving Average | 1.25 |
| 200-Day Moving Average | 2.22 |
| Relative Strength Index (RSI) | 40.71 |
| Average Volume (20 Days) | 223,288 |
Short Selling Information
The latest short interest is 80,782, so 3.00% of the outstanding shares have been sold short.
| Short Interest | 80,782 |
| Short Previous Month | 214,479 |
| Short % of Shares Out | 3.00% |
| Short % of Float | 3.53% |
| Short Ratio (days to cover) | 0.38 |
Income Statement
In the last 12 months, VTAK had revenue of $819,000 and -$17.18 million in losses. Loss per share was -$15.90.
| Revenue | 819,000 |
| Gross Profit | 756,000 |
| Operating Income | -12.18M |
| Pretax Income | -19.51M |
| Net Income | -17.18M |
| EBITDA | -10.07M |
| EBIT | -12.18M |
| Loss Per Share | -$15.90 |
Full Income StatementBalance Sheet
The company has $88,000 in cash and $3.85 million in debt, giving a net cash position of -$3.76 million or -$1.40 per share.
| Cash & Cash Equivalents | 88,000 |
| Total Debt | 3.85M |
| Net Cash | -3.76M |
| Net Cash Per Share | -$1.40 |
| Equity (Book Value) | 6.65M |
| Book Value Per Share | 4.06 |
| Working Capital | -3.52M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$8.30 million and capital expenditures -$17,000, giving a free cash flow of -$8.31 million.
| Operating Cash Flow | -8.30M |
| Capital Expenditures | -17,000 |
| Depreciation & Amortization | 2.12M |
| Net Borrowing | 423,000 |
| Free Cash Flow | -8.31M |
| FCF Per Share | -$3.09 |
Full Cash Flow StatementMargins
| Gross Margin | 92.31% |
| Operating Margin | -1,487.30% |
| Pretax Margin | -2,381.56% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |